BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19328632)

  • 1. TRPV1: a potential target for antiepileptogenesis.
    Fu M; Xie Z; Zuo H
    Med Hypotheses; 2009 Jul; 73(1):100-2. PubMed ID: 19328632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished response of CA1 neurons to antiepileptic drugs in chronic epilepsy.
    Schaub C; Uebachs M; Beck H
    Epilepsia; 2007 Jul; 48(7):1339-50. PubMed ID: 17441992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain.
    Cristino L; Starowicz K; De Petrocellis L; Morishita J; Ueda N; Guglielmotti V; Di Marzo V
    Neuroscience; 2008 Feb; 151(4):955-68. PubMed ID: 18248904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPV1 Channel: A Potential Drug Target for Treating Epilepsy.
    Nazıroğlu M
    Curr Neuropharmacol; 2015; 13(2):239-47. PubMed ID: 26411767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology and mechanism of action of zonisamide.
    Biton V
    Clin Neuropharmacol; 2007; 30(4):230-40. PubMed ID: 17762320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain TRPV1: a depressing TR(i)P down memory lane?
    Di Marzo V; Gobbi G; Szallasi A
    Trends Pharmacol Sci; 2008 Dec; 29(12):594-600. PubMed ID: 18947889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy.
    Löscher W
    Epilepsia; 2007 Jul; 48(7):1245-58. PubMed ID: 17441999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of antiepileptic drugs.
    White HS; Smith MD; Wilcox KS
    Int Rev Neurobiol; 2007; 81():85-110. PubMed ID: 17433919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of focal epilepsy.
    De Deyn PP; D'Hooge R
    Acta Neurol Belg; 1999 Dec; 99(4):222-5. PubMed ID: 10674138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the TRPV1 endogenous agonist N-Oleoyldopamine in modulation of nociceptive signaling at the spinal cord level.
    Spicarova D; Palecek J
    J Neurophysiol; 2009 Jul; 102(1):234-43. PubMed ID: 19369364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal lobe epilepsy is a disease of faulty neuronal resonators rather than oscillators, and all seizures are provoked, usually by stress.
    Eggers AE
    Med Hypotheses; 2007; 69(6):1284-9. PubMed ID: 17512676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synaptic physiology of the kainate receptors and its influence in epileptogenesis].
    Lerma J
    Neurologia; 2004 Apr; 19(3):106-16. PubMed ID: 15088160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is hippocampal atrophy a future drug target?
    Dhikav V; Anand KS
    Med Hypotheses; 2007; 68(6):1300-6. PubMed ID: 17098374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of action of antiepileptic drugs and new antiepileptic drugs].
    Armijo JA; Adin J; Sánchez MB
    Rev Neurol; 2006 Oct; 43 Suppl 1():S17-41. PubMed ID: 17061186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanisms of drug resistance in epilepsy].
    Lasoń W
    Przegl Lek; 2006; 63(11):1218-20. PubMed ID: 17348420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogens and epilepsy: why are we so excited?
    Velísková J
    Neuroscientist; 2007 Feb; 13(1):77-88. PubMed ID: 17229977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal treatment for refractory epilepsy: hope for the future?
    Nilsen KE; Cock HR
    Brain Res Brain Res Rev; 2004 Mar; 44(2-3):141-53. PubMed ID: 15003390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the novel three 'D's of epilepsy treatment: drugs, delivery systems and devices.
    Pathan SA; Jain GK; Akhter S; Vohora D; Ahmad FJ; Khar RK
    Drug Discov Today; 2010 Sep; 15(17-18):717-32. PubMed ID: 20603226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPV1: a useful therapeutic target for patients with vulnerable coronary plaques.
    Li YB; Huang CX
    Med Hypotheses; 2011 Sep; 77(3):453-5. PubMed ID: 21733634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.